Scarica l'app Stockscreener
2.16
1.41%
0.03
Dopo l'orario di chiusura:
2.16
X T L Biopharmaceuticals Ltd Adr Borsa (XTLB) Ultime notizie
XTL Biopharmaceuticals (XTLB) Trades Flat at $2.56, Sitting Midway Between Support and ResistanceLiquidity Sweep - dars.gov.et
XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition - TipRanks
XTL Biopharmaceuticals Ltd. Sponsored ADR Revenue Breakdown – FWB:HHB0 - TradingView
XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period - The Globe and Mail
XTLB Stock Price, Quote & Chart - ChartMill
Enterprise value to EBITDA forward of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView
XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine - TipRanks
XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase - TipRanks
Wondering what's happening in today's after-hours session? - ChartMill
XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026 - TipRanks
XTL Biopharmaceuticals (XTLB) Stock Price, News & Analysis $XTLB - MarketBeat
XTLB - Finviz
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report - TipRanks
XTL Biopharmaceuticals faces additional Nasdaq delisting risk - Investing.com
Eastern International Ltd. expands board, appoints two new directors - Investing.com
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise - The Globe and Mail
SMX increases authorized shares for incentive plan and grants restricted stock units - Investing.com
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal - TipRanks
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.57% - Investing.com
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline - TipRanks
XTL Biopharmaceuticals to acquire Psyga Bio for 40% stake - Investing.com
Triangle DescendingStock ScreenerCharts - Finviz
Top GainersStock ScreenerSnapshot - Finviz
XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB - Hargreaves Lansdown
Debt to assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView
Total assets of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView
Free cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — SWB:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – LSX:A41X7J - TradingView
Average basic shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView
Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets
XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LSX:A41X7J - TradingView
Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView
Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets
XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LS:A41X7J - TradingView
Long term debt to total equity ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – MUN:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Income Statement – MUN:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Earnings and Revenue – MUN:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Financial Statements – MUN:HHB0 - TradingView
Diluted shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – FWB:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Income Statement – FWB:HHB0 - TradingView
Net margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – FWB:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Financial Statements – FWB:HHB0 - TradingView
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026 - The Globe and Mail
XTL Biopharmaceuticals Announces ADS Ratio Change - Yahoo Finance
ADR Ratio Change - Yahoo Finance
XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires - TipRanks
XTL Biopharmaceuticals faces Nasdaq delisting notice - Investing.com
XTL Biopharmaceuticals shareholders approve share capital increase and private placement - Investing.com
XTL Biopharmaceuticals Ltd ADR (NASDAQ: XTLB) Stock Price, News & Analysis - kalkine.ca
The trading volume of these stocks is deviating from the norm in today's session. - ChartMill
XTL Biopharmaceuticals Moves to Acquire NeuroNOS Stake from Beyond Air and Plans $2 Million Private Placement - TipRanks
XTL Biopharmaceuticals Takes Major Impairment on The Social Proxy in First-Half 2025 Results - TipRanks
XTL Biopharmaceuticals Faces Nasdaq Bid-Price Deficiency, Given Until June 2026 to Regain Compliance - TipRanks
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - Yahoo Finance
These stocks that are showing activity before the opening bell on Friday. - ChartMill
Traders are paying attention to the gapping stocks in Wednesday's session. - ChartMill
XTL Biopharmaceuticals Ltd. (ADR) (XTLB) Live Share Price, Invest From India - INDmoney
XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks
XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — NASDAQ:XTLB - TradingView
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
These stocks have an unusual volume in today's session - ChartMill
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):